Manu Ohri

Insider Reports History

Location
Irvine, CA
Signature
/s/ Jeff Brown, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Manu Ohri:

Company Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. CFO & Secretary Common Stock 300,000 $86,100 $0.2870 11 Aug 2023 By Anarjay Concepts, Inc.
GT Biopharma, Inc. CFO & Secretary Common Stock 50,000 $14,350 $0.2870 11 Aug 2023 By Ohri Family Revocable Trust U/A Dated 02/10/2020
Axil Brands, Inc. Director Common Stock 10,000 $1,200 $0.1200 13 Jan 2025 By Anarjay Concepts Inc.
Axil Brands, Inc. Director Common Stock 10,001 $600 $0.1200 13 Jan 2025 Direct
GT Biopharma, Inc. CFO & Secretary Common Stock 0 $0.2870 11 Aug 2023 Direct

Insider Reports Filed by Manu Ohri

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AXIL Axil Brands, Inc. 13 Jan 2025 1 $0 4 Director 13 Jan 2025, 06:00
AXIL Axil Brands, Inc. 14 Feb 2024 1 $0 4 Director 20 Feb 2024, 16:32
AXIL Axil Brands, Inc. 14 Feb 2024 0 $0 3 Director 20 Feb 2024, 16:30
GTBP GT Biopharma, Inc. 11 Aug 2023 3 +$57,400 4 CFO & Secretary 15 Aug 2023, 19:26
GTBP GT Biopharma, Inc. 06 Apr 2023 1 +$25,000 4 CFO & Secretary 10 Apr 2023, 17:26
GTBP GT Biopharma, Inc. 27 Jan 2023 1 $0 4 Chief Financial Officer 01 Feb 2023, 05:02
GTBP GT Biopharma, Inc. 15 Jul 2022 4 $0 4 CFO & Secretary 19 Jul 2022, 21:44
GTBP GT Biopharma, Inc. 14 Feb 2022 0 $0 3 Chief Financial Officer 18 Feb 2022, 18:05